In December 2024, a 42-year-old Swedish man with type 1 diabetes received 17 injections of donated islet cells. They had been genetically modified via CRISPR to avoid the need for immunosuppressive medicine.
Read Entire Article
Technology
Diabetes patient produces own insulin after gene-edited cell transplant – without anti-rejection drugs
